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Recombinant human transforming rowth factor 82 (TGF;B?) was cloned and expressed in E. co/i. The protein was isolated from inclusion bodies, 
renatured and purified to a single component as judged by revcrscd+hase HPLC. The recombinant TGF$2 was shown to have a biological activity 
equal to that of native TGF;B2 in a fibroblast migration assay. Pure, aclive recombinant TGF;B2 has been crystallizd from polyethylene 
400. The trigonal crystals of spacegroup P3,21 or P3,21 have unit cell dimensions of o=b=G0.6 A, ~~75.2 A and diffract beyond 2.0 f 
ycol 
. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Transforming rowth factor type-p (TGF-B) refers to 
a family of structurally conserved polypeptides which 
regulate a wide range of growth and differentiation 
processes. In addition to the five currently described 
TGF-/3 isoforms, which are highly conserved through- 
out different species, there also exist a number of other 
related proteins which show a widespread evolutionary 
distribution and which appear to play important roles 
during development [ 1,2]. 
2.1. Esprcssio~~. isokiicut mtd pur~#kurivn 
TGF$2, the second reported TGF-/? isoform, has 
been purified from various natural sources including 
porcine platelets [3], human adenocarcinoma [4,5], 
human glioblastoma [6], simian epithelial kidney cells 
[7], bovine bone [8,9] and bovine milk [IO,1 11. TGF-p2 
has a molecular weight of approximately 25 kDa and 
consists of two identical polypeptide chains covalently 
linked by one or more disulfide bonds [4]. TGF-,82 has 
been shown to have important roles in mouse embryo- 
genesis [12], wound healing (Cox, D.A. et al., personal 
communication), bone formation [13], as well as in 
modulation of immune functions [6]. To date no studies 
have reported successful crystallization of any member 
protein. of the TGF-,B superfamily. Recent develop- 
ments in expression and refolding from E. coii have now 
provided recombinant material of TGF-,82 to make 
such studies possible. The present work describes the 
crystallization and preliminary X-ray analysis of recom- 
binant human TGF-/?2. 
Recombinant human TGF-@2 was prepared and assayed for biolog- 
ical activity as will be described (Cerletti. N. et al.. in preparation). 
Brielly. TGF-B2 cDNA encoding the Mature 112 amino acid polypcp- 
tide was cloned into theexpression plasmid. pPLMu via the NcollSu/l 
restriction sites. Plasmid pPLMu is pPLMuSMCori (obtained from 
Biogen S-A., Cambridge, MA) [14] with the pUC8 polycloning site 
between the Ncol site which Mdes for the initiating AUG and the 
Bur),HI site. Plasmid pPLMuhTGF$?2 was transformed into the B 
co/i strain, SG936 (obtained from F. Goldberg). harbouring plasmid 
pC&,. which codes for the thermolabile bacteriophage lambda cl 
repressor and confers resistance to kanamycin [15]. The transformed 
cells were grown at 30°C to ODIM 1.0. whereafter the culture was 
heat-shocked to42OC and grown for 5 h at this temperature. Mono- 
meric denatured TGF-/32 was solubilized from inclusion bodies under 
acid conditions (pH 2,s) and purified by size-exclusion chromalogra- 
phy. Ret’olding into the biologically active. dimeric form was then 
performed at pH 8.0 in the presence of a redox system and the non- 
denaturing detergent 3-[(3-cholamidopropyl)-dimethylammonio]- 
propanesulfonate (CHAPS) [16]. Correctly folded dimcric TGF@ 
was separated from residual monomeric protein by cationexchange 
chromatography and reversed-phase HPLC. The recombinant dimeric 
TGF-B2 was eluted as a single homogeneous peak which had the same 
retention time as the nntural reference protein. and was shown to have 
the correct amino acid sequence. Biologjcal activity of the recombi- 
nant protein was shown to be identical to that of natural protein in 
a previously described invitro bioassay [IO]. which measures the level 
of BALBlc 3T3 fibroblast migration in response to natural and recom- 
binant TGF-82 (Fig. 1). 
22. Cryslallimion 
Corres~ondcnce addrpss: M.G. GrLltter, Department of Biotechnol- 
ogy, Pharmaceuticals Division, Ciba.Geigy Ltd., Ch-4002 Basel, Swit- 
zerland. Fax: (41) (61) 696 4069. 
Crystals were flown using the hanging drop method [171 at room 
temoerature. Lvoahilized TGF-132 was dissolved in 10 mM sodium 
x&ate buffer 81 $I 3.0 (proteih conantration 5 m&ml). The drop. 
typically 2 ~1 of protein solution and 2 PI of reservoir solution, was 
equilibrated against abufferconsistingofO.1 M sodium acetate buffer, 
pH 4.5-5.0. and 25-35% (w/v) polyethylene glycol 400 (PEG 400). 
2.3. Heavy ufont derivarive preparakm 
For data collection, as well as for heavy atom derivative soaks, 
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crystals were transferred frc3 !he crysta\liPation drop to a stabilizing 
solution consisting of 30-338 PEG 400 in 0.1 M sodium acetate 
buffer, pH 4.8. Heavy atom derivatives were prepared by soakins 
recombinant human TGF-p2 crystals in this stabilizing solution to 
which the appropriate heavy atom compound had been added. 
TGF-B2 crysr.als. from which all surrounding mother liquor had 
been remo:ed by pipetting, were placed into a mixtwe of bromobcn- 
zene and xylene of known density [!8]. The ratio of the two com- 
pounds was adjusted until the crystal remained suspended at the same 
place. The V,,, was calculated as described by Matthews [19]. 
2.5. X-Ru.v d$frucrion twasrrremmrs 
X-Ray diffraction data were collected using a FAST area detector 
(Enraf-Nonius, Delft. The Netherlands). Graphite-monochromatcd 
CuKcc radiation was provided by an FR571 X-ray generator operated 
at 40 kV and 70 mA with an apparent focal spot of 0.3 x 0.3 mm’. The 
capillary was mounted on a 4-circle EC goniostat and was rotated 90” 
about the o-axis about an arbitrary crystal axis in steps of 0. lo/frame 
with an exposure time of 60 s/frame. The 28 swing-out angle for the 
detector was set at -10” for data collection to 2.4 A resolution or to 
-20° for collection to 1.8 A resolution, with a crystal-to-detector 
distance of 50 mm, Crystal orientation determination, data collection 
and on-line data evaluation were performed using the program MAD- 
NES [20]. The measured intensity data were profile-fitted and scaled 
together using the program PROCOR [2!]. Data reduction and mcrg- 
ing were performed using the program package CCP4 (Daresbury 
Laboratory). 
3. RESULTS 
Optimal crystallization of recombinant human TGF- 
82 occurred at pH 4.8 and 30% PEG 400 resulting in 
crystals of 0.2 x 0.2 x 0.15 mm3 size that diffracted to 
beyond 2.0 A. The space group was determined to be 
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Fig. 1. Stimulation of BALB/c 3T3 Abroblast migration. Wounded 
confluent monolayers of BALB/c 3T3 Abroblasrs were incubated for 
32 h in serum-free medium containing varying amounts of either, (a) 
refolded and purified recombinant human TGF-p2 (solid circles), or 
(b) natural bovine TGF# isolatzzl from milk (open circtcs). Values 
represent the number of cells that have migrated across 1.2 mm of 
wound edge (one optical field of vision) at each concentration of 
TGF-j2. Each value represents the mean f S.E.M. of six determina- 
tions from duplicate cultures. 
P3,21 or the enantiomorph P3121. Systematic absences 
for the 001 reflections 123 n indicated a 3-fold screw 
axis along c, The hk0 reflections showed clearly the 
2-fold axis perpendicular to the c-axis. The unit cell 
edges were determined to be a=b=60,6 A, c=75.2 A. 
There is either one molecule (V,, = 3.13 A3/Da) or two 
(V,,,=1.57 A’/Da) per asymmetric unit. Crystal density 
measurements gave a density of 1.07 g/cm” implying a 
V,,, of about 3.2 A3/Da (data not shown). The first crys- 
tal, which was measured to 2.4 A, provided a total of 
29,107 reflections which were reduced and merged to 
6,560 unique reflections (97.4% completeness in the last 
resolution range from 2.53-2,4 A) with an Rmcrgo de- 
fined as Z(lI- I}l)/ZI, of 0.094. A second crystal, meas- 
ured to 1.8 A provided a total of 36,217 reflections 
which were red;lced and merged to 14,995 unique reflec- 
tions (94.5% completeness in the last resolution range 
from 1.9-1.8 A> with an Rnrergc of 0.106. Potential heavy 
atom derivatives were prepared with different mercury, 
platinum, gold and uranyl compounds. Several deriva- 
tive data sets were collected. Evaluation of heavy atom 
derivative sites and structure solution are currently 
under way. 
4. DISCUSSION 
The high-diffraction quality of the trigonal TGF-p2 
crystals provides a good basis for the preparation of 
suitable heavy atom derivatives that should finally yield 
a complete structure of the TGF-p2 molecule. Consider- 
ing the similarities between members of the TGF-p fam- 
ily, such a model may well be the basis for studies of 
other TGF-b isoforms and related proteins of the TGF- 
p family. These include Mullerian inhibitory substance 
(MIS) [22] which causes regression of the Mullerian 
duCL during development OC the male embryo; the inhib- 
insiactivins [23], proteins which regulate FSH secretion 
by pituitary cells; the decapentaplegic gene product dpp 
of Drosopkih [24,25] which influences dorsoventral 
specification and morphogenesis of the imaginal discs; 
the Vg-1 gene product of Xwopus [26,27] which local- 
izes to the vegetal pole of the egg; Vgr-1, the mammalian 
homologue of Vg-I [28] which is expressed during 
mouse embryogenesis; OP-1, the predicted human hom- 
ologue of a major component of bovine osteogenic pro- 
tein [29]; GDF-1 [30] another Vg-I related molecule 
which is expressed in early mouse embryos, and the 
bone morphogenetic proteins (BMPs) [31,32] which can 
induce de novo cartilage and bone formation. Besides 
their partial amino acid sequence homology to the 
TGF-p isoforms an outstanding feature of all these pro- 
teins is the strong positional conservation of cysteine 
residues, suggesting that these molecules may have sim- 
ilar 3D structures. Resolution of their structures will 
give useful insights into a better understanding of the 
actions and the biological roles of these important mol- 
ecules. 
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